A. COVID 19
B. Lung Cancer
C. Brain Diseases
D. Liver Diseases
Answer
Correct Answer: B. Lung Cancer
Detail About MCQs
Osimertinib is a new drug capable of cutting the risk of death from lung cancer by half. Lung cancer accounts for around 1.8 million deaths each year.
Taking the drug daily after surgery reduced non-small cell lung cancer patients’ death risk by more than 50%.